Showing results (791-800 of 3,698) with videos related to

Sort By:
Pageof 370
International Journal of Clinical Oncology|October 21, 2025
Diagnosis and treatment strategies for hereditary pancreatic cancer syndromeHiroyuki Matsubayashi, Chigusa Morizane, Masashi Kanai, et al.
International Journal of Clinical Oncology|October 21, 2025
Current status and prospects of computer-assisted surgery (CAS) in oral and maxillofacial reconstructionYoshihiro Morita, Narikazu Uzawa
International Journal of Clinical Oncology|September 12, 2025
Socioeconomic disparities in colorectal cancer oncologic emergencies: a nationwide multilevel analysis in JapanMariko Hanafusa, Nobutoshi Nawa, Masato Ota, et al.
International Journal of Clinical Oncology|August 14, 2025
A phase II study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in patients with colorectal cancer receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study)Yohei Iimura, Keisuke Baba, Naoki Furukawa, et al.
International Journal of Clinical Oncology|February 17, 2026
Comparative efficacy of immune checkpoint inhibitor-based regimens versus tyrosine kinase inhibitors in advanced hepatocellular carcinoma stratified by etiology: a systematic review and meta-analysisTzu-Rong Peng, Yun-Hui Huang, Ta-Wei Wu, et al.
International Journal of Clinical Oncology|November 15, 2022
Survival after laparoscopic radical surgery for stage IA-IIB cervical cancer: 1316 consecutive cases from a national laparoscopic training center in ChinaYuhui Huang, Jing Cai, Hongbo Wang, et al.
International Journal of Clinical Oncology|November 15, 2022
Prognostic impact of tumor microenvironment-related markers in patients with adenocarcinoma of the lungMayu Sugai, Naoki Yanagawa, Shunsuke Shikanai, et al.
International Journal of Clinical Oncology|January 31, 2026
Identifying immune-related predictive factors for post-eribulin therapy in patients with HER2-negative advanced breast cancer- a multicenter retrospective studyYuri Takamatsu, Yoshiya Horimoto, Yasuo Miyoshi, et al.
International Journal of Clinical Oncology|February 9, 2026
Modified EXTREME regimen versus modified TPEx regimen as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, open-label, randomized, exploratory study (TEMPER study)Motoyuki Suzuki, Akehito Kishino, Masashi Sugasawa, et al.
International Journal of Clinical Oncology|January 28, 2026
Intratumoral heterogeneity and chemotherapy-induced alteration of CLDN18.2 expression in resectable gastric cancerShinnosuke Nagano, Yukinori Kurokawa, Takaomi Hagi, et al.
Pageof 370